Danielle Rollmann

Danielle Rollmann, M.P.A., serves as Vice President, Market Access Policy at the Janssen Pharmaceutical Companies of Johnson & Johnson. She and her team work to advance policy on priority issues globally that affect patient access to innovative medicines through integrated, cross-functional policy development and external dialogue. Ms. Rollmann has over 25 years’ experience in pharmaceutical policy roles and business consulting, where she served serving clients in the pharmaceutical, diagnostics, consumer health, and other life sciences industries as an advisor on commercial innovation, growth and marketing strategy, and business transformation.